Skip to content Skip to footer

Close

Sartar was granted a Japan patent

January 25, 2019

Sartar was awarded a patent in Japan for the use of anagrelide in cancer therapy.

Tags: growth innovation life science patent research start-up technology

You May Also Like

Sartar was chosen among the top 30 innovative life science companies in RESI Innovation Challenge

Sartar was awarded a U.S. patent

Sartar Therapeutics was selected to NOME mentoring program